BRAIN Biotech AG
XETRA:BNN
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1.445
4.24
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Abbvie Inc
NYSE:ABBV
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Realty Income Corp
NYSE:O
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
BRAIN Biotech AG
BRAIN Biotech AG
Cash from Operating Activities
BRAIN Biotech AG
Cash from Operating Activities Peer Comparison
WCH
EVK
1COV
ACT
SY1
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
BRAIN Biotech AG
XETRA:BNN
|
Cash from Operating Activities
-€1.8m
|
CAGR 3-Years
15%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Wacker Chemie AG
XETRA:WCH
|
Cash from Operating Activities
€588.8m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
8%
|
CAGR 10-Years
1%
|
|
|
Evonik Industries AG
XETRA:EVK
|
Cash from Operating Activities
€2.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
1%
|
CAGR 10-Years
6%
|
|
|
Covestro AG
XETRA:1COV
|
Cash from Operating Activities
€863m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
|
AlzChem Group AG
XETRA:ACT
|
Cash from Operating Activities
€72.7m
|
CAGR 3-Years
14%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
|
Symrise AG
XETRA:SY1
|
Cash from Operating Activities
€851.9m
|
CAGR 3-Years
16%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
See Also
What is BRAIN Biotech AG's Cash from Operating Activities?
Cash from Operating Activities
-1.8m
EUR
Based on the financial report for Jun 30, 2024, BRAIN Biotech AG's Cash from Operating Activities amounts to -1.8m EUR.
What is BRAIN Biotech AG's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-2%
Over the last year, the Cash from Operating Activities growth was 63%. The average annual Cash from Operating Activities growth rates for BRAIN Biotech AG have been 15% over the past three years , -2% over the past five years .
You don't have any saved screeners yet
